abstract |
The present invention provides novel inhibitors of Factors VIIa, IXa, Xa, XIa, in particular Factor VIIa, pharmaceutical compositions comprising such inhibitors, and methods of using these inhibitors for the treatment or prevention of thromboembolic disease, cancer or rheumatoid arthritis. It is about. Methods of making such inhibitors are also described. |